[DPHARMA] QoQ TTM Result on 30-Jun-2021 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
17-Aug-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
30-Jun-2021 [#2]
Profit Trend
QoQ- 1.05%
YoY- 14.75%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Revenue 658,662 639,175 627,817 589,751 577,643 569,902 573,571 9.66%
PBT 86,454 82,984 86,327 82,412 81,606 76,157 69,625 15.54%
Tax -18,094 -17,301 -20,167 -19,088 -18,943 -17,547 -15,175 12.45%
NP 68,360 65,683 66,160 63,324 62,663 58,610 54,450 16.39%
-
NP to SH 68,360 65,683 66,160 63,324 62,663 58,610 54,450 16.39%
-
Tax Rate 20.93% 20.85% 23.36% 23.16% 23.21% 23.04% 21.80% -
Total Cost 590,302 573,492 561,657 526,427 514,980 511,292 519,121 8.95%
-
Net Worth 621,987 621,564 612,147 614,350 635,424 642,484 584,565 4.22%
Dividend
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Div 20,482 20,482 45,892 45,892 45,783 45,783 37,536 -33.24%
Div Payout % 29.96% 31.18% 69.37% 72.47% 73.06% 78.12% 68.94% -
Equity
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Net Worth 621,987 621,564 612,147 614,350 635,424 642,484 584,565 4.22%
NOSH 941,765 941,765 941,765 706,330 706,026 706,026 706,026 21.19%
Ratio Analysis
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
NP Margin 10.38% 10.28% 10.54% 10.74% 10.85% 10.28% 9.49% -
ROE 10.99% 10.57% 10.81% 10.31% 9.86% 9.12% 9.31% -
Per Share
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
RPS 70.95 67.87 66.66 83.52 81.82 80.72 82.42 -9.51%
EPS 7.36 6.97 7.03 8.97 8.88 8.30 7.82 -3.96%
DPS 2.21 2.17 4.87 6.50 6.48 6.48 5.50 -45.57%
NAPS 0.67 0.66 0.65 0.87 0.90 0.91 0.84 -14.00%
Adjusted Per Share Value based on latest NOSH - 706,330
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
RPS 68.47 66.45 65.27 61.31 60.05 59.24 59.63 9.66%
EPS 7.11 6.83 6.88 6.58 6.51 6.09 5.66 16.43%
DPS 2.13 2.13 4.77 4.77 4.76 4.76 3.90 -33.20%
NAPS 0.6466 0.6462 0.6364 0.6387 0.6606 0.6679 0.6077 4.22%
Price Multiplier on Financial Quarter End Date
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Date 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 -
Price 1.49 1.68 1.81 3.03 2.75 3.38 3.16 -
P/RPS 2.10 2.48 2.72 3.63 3.36 4.19 3.83 -33.03%
P/EPS 20.23 24.09 25.76 33.79 30.98 40.72 40.39 -36.95%
EY 4.94 4.15 3.88 2.96 3.23 2.46 2.48 58.37%
DY 1.48 1.29 2.69 2.15 2.36 1.92 1.74 -10.23%
P/NAPS 2.22 2.55 2.78 3.48 3.06 3.71 3.76 -29.64%
Price Multiplier on Announcement Date
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Date 17/05/22 15/02/22 18/11/21 17/08/21 03/05/21 22/02/21 12/11/20 -
Price 1.51 1.60 1.62 2.49 2.93 3.42 4.04 -
P/RPS 2.13 2.36 2.43 2.98 3.58 4.24 4.90 -42.64%
P/EPS 20.51 22.94 23.06 27.77 33.01 41.20 51.63 -45.99%
EY 4.88 4.36 4.34 3.60 3.03 2.43 1.94 85.06%
DY 1.46 1.36 3.01 2.61 2.21 1.90 1.36 4.84%
P/NAPS 2.25 2.42 2.49 2.86 3.26 3.76 4.81 -39.76%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment